— Why it moved
Why BIAF Stock Spiked and Collapsed Today — September 17, 2026
bioAffinity Technologies caught a midday momentum surge on a Hong Kong patent grant, but the alert arrived at the literal peak before a heavy unwind.
What moved BIAF stock
bioAffinity Technologies develops noninvasive diagnostic tests for early lung cancer detection. The jump came after news broke that Hong Kong granted a patent for their CyPath Lung testing platform. Overseas patent headlines sound impressive in PR blasts, but they rarely translate to near-term revenue for tiny biotech outfits.
The mechanics
A microscopic float of 532,257 shares made violent swings guaranteed. Over 25 million shares turned over during the session, showing classic low-float churn as momentum volume flooded in after a solid gap at the session's start.
BIAF by the numbers
The alert window
This alert gave traders zero usable edge. The signal went out at 12:47 PM at 9.89, which happened to be the exact minute the stock topped out at 10.24. Sitting through a microscopic 0.1% dip brought a brief 3.5% peak before the entire move fell apart.
How BIAF's move ended
Price action disintegrated immediately, spending just one minute above the alert price. The stock bled down the rest of the afternoon to close at 8.83, down 10.7% from the signal level. With a market cap near three million dollars, chasing a midday spike on this setup meant providing exit liquidity.
The tell: If the alert minute marks the session high on a tiny float, the trade was already over before you saw it.